HIV testing factors associated with delayed entry into HIV medical care among HIV-infected persons from eighteen states, United States, 2000-2004

AIDS Patient Care and STDs

Volumn 23, Issue 9, 2009, Pages 765-773

  Reed, J Bailey ^a   Hanson, Debra ^a   McNaghten, A D ^a   Bertolli, Jeanne ^a   Teshale, Eyasu ^a   Gardner, Lytt ^a   Sullivan, Patrick ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; RISK FACTOR; SEMI STRUCTURED INTERVIEW; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; ATTITUDE TO HEALTH; CONFIDENTIALITY; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HIV-1; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; POPULATION SURVEILLANCE; QUESTIONNAIRES; RISK FACTORS; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 70349200992     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2008.0213     Document Type: Article

References (64)

1. Centers for Disease Control and Prevention. Late vs. early testing of HIV-16 sites, United States, 2000-2003. MMWR 2003;52:581-586.
2. Wortley PM, Chu SY, Diaz T, et al. HIV testing patterns: where, why, and when were persons with AIDS tested for HIV? AIDS 1995;9:487-492.
3. Centers for Disease Control and Prevention. HIV prevalence estimates-United States, 2006. MMWR Morb Mortal Wkly Rep 2008;57:1073-1076.
4. Keruly JC, Moore RD. Immune status at presentation to care did not improve among antiretroviral-naive persons from 1990 to 2006. Clin Infect Dis 2007;45:1369-1374.
5. Bindman AB, Osmond D, Hecht FM, et al. Multistate evaluation of anonymous HIV testing and access to medical care. Multistate Evaluation of Surveillance of HIV (MESH) Study Group. JAMA 1998;280:1416-1420.
6. Fleming P, Byers RH, Sweeney PA, Daniels D, Karon JM, Janssen RS. HIV prevalence in the United States, 2000 [Abstract 11]. 9th Conference on Retroviruses and Opportunistic Infections, Seattle, 2002.
7. Giordano TP, Visnegarwala F, White AC, Jr. et al. Patients referred to an urban HIV clinic frequently fail to establish care: Factors predicting failure. AIDS Care 2005;17:773-783.
8. Guenter CD, Gill MJ. A population with short delay from diagnosis of human immunodeficiency virus to medical care. Arch Intern Med 1999;159:758-759.
9. Ickovics JR, Forsyth B, Ethier KA, Harris P, Rodin J. Delayed entry into health care for women with HIV disease. AIDS Patient Care STDs 1996;10:21-24.
10. Krawczyk CS, Funkhouser E, Kilby JM, Kaslow RA, Bey AK, Vermund SH. Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV=AIDS clinic. South Med J 2006;99:472-481.
11. Milberg J, Sharma R, Scott F, Conviser R, Marconi K, Par-ham D. Factors associated with delays in accessing HIV primary care in rural Arkansas. AIDS Patient Care STDs 2001;15:527-532.
12. Molitor F, Walsh RM, Leigh JP. Determinants of longer time from HIV result to enrollment in publicly funded care and treatment in California by race=ethnicity and behavioral risk. AIDS Patient Care STDs 2002;16:555-565.
13. Samet JH, Freedberg KA, Stein MD, et al. Trillion virion delay: Time from testing positive for HIV to presentation for primary care. Arch Intern Med 1998;158:734-740.
14. Turner BJ, Cunningham WE, Duan N, et al. Delayed medical care after diagnosis in a US national probability sample of persons infected with human immunodeficiency virus. Arch Intern Med 2000;160:2614-2622.
15. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Morb Mortal Wkly Rep 2006;55:1-17.
16. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. MMWR Morb Mortal Wkly Rep 2001;50:1-58.
17. AIDSInfo. DHHS panel on antiretoviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. AIDSInfo. October 10, 2006. http:AIDSinfo.NIH.gov. (Last accessed October 10, 2008).
18. Hammer SM, Saag MS, Schechter M, et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA 2006;296: 827-843.
19. Egger M, May M, Chene G, et al. Prognosis of HIV-1infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies. Lancet 2002; 360:119-129. (Pubitemid 34786200)
20. Kaplan JE, Hanson D, Dworkin MS, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000;30(Suppl 1): S5-14.
21. McNaghten AD, Hanson DL, Jones JL, Dworkin MS, Ward JW. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult=Adolescent Spectrum of Disease Group. AIDS 1999;13:1687-1695.
22. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
23. Lichtenstein KA, Armon C, Buchacz K, et al. Initiation of antiretroviral therapy at CD4 cell counts 2350 cells=mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insuficiency. J Acquir Immune Defic Syndr 2008;47:27-35.
24. Moore RD, Keruly JC. CD4+cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis 2007;44:441-446.
25. Phillips AN, Gazzard BG, Clumeck N, Losso MH, Lundgren JD. When should antiretroviral therapy for HIV be started? BMJ 2007;334:76-78.
26. Hisada M, O'Brien TR, Rosenberg PS, Goedert JJ. Virus load and risk of heterosexual transmission of human immunodeficiency virus and hepatitis C virus by men with hemophilia. The Multicenter Hemophilia Cohort Study. J Infect Dis 2000;181:1475-1478.
27. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921-929.
28. Fisher JD, Cornman DH, Osborn CY, Amico KR, Fisher WA, Friedland GA. Clinician-initiated HIV risk reduction intervention for HIV-positive persons: Formative Research, Acceptability, and Fidelity of the Options Project. J Acquir Immune Defic Syndr 2004;37(Suppl 2):S78-S87.
29. Richardson JL, Milam J, McCutchan A, et al. Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: A multi-clinic assessment. AIDS 2004;18: 1179-1186.
30. Centers for Disease Control and Prevention. HIV prevention strategic plan for 2005. Centers for Disease Control and Prevention. www.cdc.gov=hiv=patners= psp.htm (Last accessed August 4, 2003).
31. Centers for Disease Control and Prevention. HIV prevention strategic plan: Extended through 2010. Centers for Disease Control and Prevention 2007 October. www.cdc.gov=hiv=resources=reports=psp=index.htm (Last accessed August 4, 2003).
32. Centers for Disease Control and Prevention. HIV=AIDS Surveillance Report, 2005. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
33. Mayben JK, Kramer JR, Kallen MA, Franzini L, Lairson DR, Giordano TP. Predictors of delayed HIV diagnosis in a recently diagnosed cohort. AIDS Patient Care STDs 2007;21: 195-204.
34. Abdi H. Bonferroni and Sidak corrections for multiple comparisons. In: Salking NJ, ed. Encyclopedia of Measurement Statistics. Thousand Oaks, CA: Sage; 2007, 103-106.
35. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006;20:1447-1450.
36. Cabral HJ, Tobias C, Rajabiun S et al. Outreach program contacts: Do they increase the likelihood of engagement and retention in HIV primary care for hard-to-reach patients? AIDS Patient Care STDs 2007;21(Suppl 1):S59-S67.
37. Craw JA, Gardner LI, Marks G, et al. Brief strengths-based case management promotes entry into HIV medical care: Results of the antiretroviral treatment access study-II. J Acquir Immune Defic Syndr 2008;47:597-606.
38. Raveis VH, Siegel K, Gorey E. Factors associated with HIV-infected women's delay in seeking medical care. AIDS Care 1998;10:549-562.
39. Foley EE. HIV=AIDS and African immigrant women in Philadelphia: Structural and cultural barriers to care. AIDS Care 2005;17:1030-1043.
40. Samet JH, Freedberg KA, Savetsky JB, Sullivan LM, Stein MD. Understanding delay to medical care for HIV infection: The long-term non-presenter. AIDS 2001;15:77-85.
41. Fehrs LJ, Fleming D, Foster LR et al. Trial of anonymous versus confidential human immunodeficiency virus testing. Lancet 1988;2:379-382.
42. Hirano D, Gellert GA, Fleming K, Boyd D, Englender SJ, Hawks H. Anonymous HIV testing: The impact of availability on demand in Arizona. Am J Public Health 1994;84:2008-2010.
43. Kegles S, Catania J, Coates T, Pollack LM. Many people who seek anonymous testing: the impact of availability on demand in Arizona. AIDS 1990;4:585-588.
44. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: Implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005;39:446-453.
45. Girardi E, Aloisi MS, Arici C, et al. Delayed presentation and late testing for HIV: Demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr 2004;36:951-959.
46. Kalichman SC, Schaper PE, Belcher L, et al. It's like a regular part of gay life: Repeat HIV antibody testing among gay and bisexual men. AIDS Educ Prev 1997;9(3 Suppl):41-51.
47. Anderson JE, Chandra A, Mosher WD. HIV testing in the United States, 2002. Adv Data 2005;363:1-32.
48. Stolte IG, Dukers NH. Response to 'High-risk sexual behaviour increases among London gay men between 1998 and 2001: What is the role of HIV optimism?'. AIDS 2003; 17:2011-2012.
49. Stolte IG, Dukers NH, Geskus RB, Coutinho RA, de Wit JB. Homosexual men change to risky sex when perceiving less threat of HIV=AIDS since availability of highly active antiretroviral therapy: A longitudinal study. AIDS 2004;18: 303-309.
50. Bezemer D, de WF, Boerlijst MC, et al. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS 2008;22:1071-1077.
51. Truong HM, Kellogg T, Klausner JD, et al. Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: A suggestion of HIV serosorting? Sex Transm Infect 2006;82:461-466.
52. Lert F. Advances in HIV treatment and prevention: Should treatment optimism lead to prevention pessimism? AIDS Care 2000;12:745-755.
53. Moyer CA, Ekpo G, Calhoun CL, et al. Quality of life, optimism=pessimism, and knowledge and attitudes toward HIV Screening among pregnant women in Ghana. Womens Health Issues 2008;18:301-309.
54. Hart GJ, Williamson LM, Flowers P, Frankis JS, Der GJ. Gay men's HIV testing behaviour in Scotland. AIDS Care 2002;14:665-674. (Pubitemid 35176929)
55. Kellerman SE, Lehman JS, Lansky A, et al. HIV testing within at-risk populations in the United States and the reasons for seeking or avoiding HIV testing. J Acquir Immune Defic Syndr 2002;31:202-210.
56. Spielberg F, Branson BM, Goldbaum GM, et al. Overcoming barriers to HIV testing: preferences for new strategies among clients of a needle exchange, a sexually transmitted disease clinic, and sex venues for men who have sex with men. J Acquir Immune Defic Syndr 2003;32:318-327.
57. Wong KH, Lee SS, Low KH, Wan WY. Temporal trend and factors associated with late HIV diagnosis in Hong Kong, a low HIV prevalence locality. AIDS Patient Care STDs 2003; 17:461-469.
58. Catania JA, Gibson DR, Chitwood DD, Coates TJ. Methodological problems in AIDS behavioral research: Influences on measurement error and participation bias in studies of sexual behavior. Psychol Bull 1990;108:339-362.
59. Cunningham CO, Li X, Ramsey K, Sohler NL. A comparison of HIV health services utilization measures in a marginalized population: Self-report versus medical records. Med Care 2007;45:264-268.
60. Kalichman SC, Rompa D, Cage M. Reliability and validity of self-reported CD4 lymphocyte count and viral load test results in people living with HIV=AIDS. Int J STD AIDS 2000;11:579-585.
61. Hessol NA, Schwarcz S, Ameli N, Oliver G, Greenblatt RM. Accuracy of self-reports of acquired immunodeficiency syndrome and acquired immunodeficiency syndrome-related conditions in women. Am J Epidemiol 2001;153:1128-1133.
62. McNaghten AD, Wolfe MI, Onorato I, et al. Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: The rationale for developing a population-based approach. PLoS ONE 2007; 2:e550.
63. Centers for Disease Control and Prevention. Surveillance of HIV-related events among persons not receiving care. Fed Regist 2005;70:38152.
64. Sullivan PS, McKenna MT, Janssen RS. Progress toward implementation of integrated systems for surveillance of HIV infection and morbidity in the United States. Public Health Rep 2007;122(Suppl 1):1-3.